CLOTRIMAZOLE 1%

N/A

Manufactured by Beautivity LLC

190 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CLOTRIMAZOLE 1%

CLOTRIMAZOLE 1% is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Beautivity LLC. The most commonly reported adverse reactions for CLOTRIMAZOLE 1% include HEADACHE, NAUSEA, FATIGUE, COUGH, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CLOTRIMAZOLE 1%.

Top Adverse Reactions

HEADACHE7 reports
NAUSEA7 reports
FATIGUE6 reports
COUGH5 reports
DIARRHOEA5 reports
PAIN5 reports
PAIN IN EXTREMITY5 reports
BACK PAIN4 reports
VOMITING4 reports
COVID 193 reports
DEATH3 reports
DIZZINESS3 reports
FALL3 reports
HYPOTENSION3 reports
INSOMNIA3 reports
OEDEMA PERIPHERAL3 reports
PRODUCTIVE COUGH3 reports
RASH3 reports
URINARY TRACT INFECTION3 reports
VISION BLURRED3 reports
WEIGHT DECREASED3 reports
ABDOMINAL PAIN2 reports
ABDOMINAL PAIN UPPER2 reports
APHONIA2 reports
ASTHENIA2 reports
BLOOD PRESSURE ABNORMAL2 reports
CARDIAC FAILURE CONGESTIVE2 reports
CELLULITIS2 reports
CONFUSIONAL STATE2 reports
DEHYDRATION2 reports
ERYTHEMA2 reports
FUNGAL INFECTION2 reports
GAIT DISTURBANCE2 reports
GOUT2 reports
HOT FLUSH2 reports
ILLNESS2 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION2 reports
INCORRECT DOSE ADMINISTERED2 reports
LETHARGY2 reports
ORAL PAIN2 reports
PLATELET COUNT DECREASED2 reports
PNEUMONIA2 reports
PRODUCT DOSE OMISSION ISSUE2 reports
PRODUCT RESIDUE PRESENT2 reports
PRURITUS2 reports
SEASONAL ALLERGY2 reports
SYNCOPE2 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS2 reports
ABDOMINAL DISCOMFORT1 reports
ABSCESS1 reports
ADVERSE DRUG REACTION1 reports
ALCOHOL ABUSE1 reports
ALOPECIA1 reports
ANAEMIA1 reports
ARTHRALGIA1 reports
ASTHMA1 reports
BALANCE DISORDER1 reports
BASAL CELL CARCINOMA1 reports
BLOOD BILIRUBIN INCREASED1 reports
BRONCHIAL HYPERREACTIVITY1 reports
BRONCHITIS1 reports
CARDIOMETABOLIC SYNDROME1 reports
CHEST DISCOMFORT1 reports
CHILLS1 reports
CHOLECYSTITIS1 reports
CHOLELITHIASIS1 reports
CHONDROCALCINOSIS1 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE1 reports
CHRONIC SINUSITIS1 reports
COATING IN MOUTH1 reports
COLITIS1 reports
COLOSTOMY1 reports
CONJUNCTIVITIS1 reports
CONTUSION1 reports
CORONARY ARTERIAL STENT INSERTION1 reports
CROHN^S DISEASE1 reports
CYSTIC FIBROSIS1 reports
DECREASED APPETITE1 reports
DEPRESSED MOOD1 reports
DEPRESSION1 reports
DEVICE TEMPERATURE ISSUE1 reports
DIVERTICULITIS1 reports
DRUG INTOLERANCE1 reports
DRY MOUTH1 reports
DRY SKIN1 reports
DYSLIPIDAEMIA1 reports
DYSPEPSIA1 reports
DYSPNOEA1 reports
DYSURIA1 reports
EMBOLISM1 reports
ENDOMETRIAL CANCER1 reports
EOSINOPHIL COUNT INCREASED1 reports
EPISTAXIS1 reports
FAECES SOFT1 reports
FISTULA1 reports
FLATULENCE1 reports
FUNGAL SKIN INFECTION1 reports
GASTRIC NEOPLASM1 reports
GASTROOESOPHAGEAL REFLUX DISEASE1 reports
HAEMOGLOBIN DECREASED1 reports

Report Outcomes

Out of 54 classified reports for CLOTRIMAZOLE 1%:

Serious 55.6%Non-Serious 44.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female32 (62.7%)
Male19 (37.3%)

Reports by Age

Age 262 reports
Age 582 reports
Age 642 reports
Age 662 reports
Age 672 reports
Age 682 reports
Age 321 reports
Age 361 reports
Age 401 reports
Age 431 reports
Age 441 reports
Age 461 reports
Age 481 reports
Age 521 reports
Age 551 reports
Age 561 reports
Age 601 reports
Age 611 reports
Age 631 reports
Age 691 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CLOTRIMAZOLE 1%?

This profile reflects 190 FDA FAERS reports that mention CLOTRIMAZOLE 1%. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CLOTRIMAZOLE 1%?

Frequently reported terms in FAERS include HEADACHE, NAUSEA, FATIGUE, COUGH, DIARRHOEA, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CLOTRIMAZOLE 1%?

Labeling and FAERS entries often list Beautivity LLC in connection with CLOTRIMAZOLE 1%. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.